Mr. Speaker, my question is for the Minister of Health. On June 8, 1992, the BioVac company of Quebec submitted an application for the licensing of its BCG-cancer vaccine. After 22 months, this application is still pending. Connaught submitted an application for a similar vaccine on March 2, 1989, and a license was issued after 14 months. This delay in the licensing process is causing serious prejudice to BioVac which stands to lose important contracts.
Could the minister tell us what is delaying unduly the licensing of the Biovac BCG-cancer vaccine?